Transaxillary TAVR With Solely Echocardiography Guidance
Key facts
- Where
- Beijing, ChinaSee the site
Where in China
- Fuwai HospitalBeijing, ChinaContact: Xiangbin PanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Trial code
- NCT07035847
- Record updated
- 27 February 2026
- Original description
This study aims to evaluate the safety and feasibility of performing transaxillary transcatheter aortic valve replacement (TA TAVR) guided solely by echocardiography in patients with severe aortic stenosis (AS).Read full original descriptionShow less
Transaxillary Transcatheter Aortic Valve Replacement With Pure Echocardiography Guidance
This study aims to evaluate the safety and feasibility of performing transaxillary transcatheter aortic valve replacement (TA TAVR) guided solely by echocardiography in patients with severe aortic stenosis (AS).
Inclusion: symptomatic severe AS determined by echocardiography and Doppler that requiring aortic valve replacement, defined as: mean gradient ≥40 mmHg, peak aortic velocity ≥4 m/s, and aortic valve area (AVA) ≤1 cm2 (or an indexed AVA ≤0.6 cm2/m2); suitable for Transaxillary TAVR.
Exclusion: required hybrid procedures or concomitant interventions on other cardiac malformations; inoperable due to extremely high surgical risk or severe comorbidities; previously undergone aortic valve replacement; untreated clinically significant (>70% obstruction) proximal vessel coronary vascular disease amenable to revascularization.